Incretin hormones and insulin sensitivity
- 30 June 2005
- journal article
- review article
- Published by Elsevier BV in Trends in Endocrinology & Metabolism
- Vol. 16 (4), 135-136
- https://doi.org/10.1016/j.tem.2005.03.002
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During HypoglycemiaDiabetes, 2004
- Exendin-4 Pharmacodynamics: Insights from the Hyperglycemic Clamp TechniqueThe Journal of pharmacology and experimental therapeutics, 2004
- Pharmacological Agents That Directly Modulate Insulin SecretionPharmacological Reviews, 2003
- Gut adaptation and the glucagon-like peptidesGut, 2002
- Biological actions and therapeutic potential of the glucagon-like peptidesGastroenterology, 2002
- Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitroMetabolism, 2001
- Minireview: The Glucagon-Like PeptidesEndocrinology, 2001
- Glucagon-Like Peptide-1Proceedings of the 1972 Laurentian Hormone Conference, 2001
- Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).Diabetes, 1999
- Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IVEndocrinology, 1995